Additionally, Spiller et al. found expression of NODAL and its cofactor CRIPTO as well as LEFTY1 in CIS and ECs and NODAL signaling might also provide a mechanism regulating potency in GCCs [28] [31]. Here, CRIPTO is linked to in situ carcinoma.